rolofylline has been researched along with urea in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Albert, NM; Butler, J; Carson, PE; Collins, SP; Colvin-Adams, M; Dimarco, JP; Ezekowitz, JA; Fang, JC; Givertz, MM; Hernandez, AF; Hershberger, RE; Katz, SD; Krishnamani, R; Rogers, JG; Spertus, JA; Starling, RC; Stevenson, WG; Stough, WG; Sweitzer, NK; Tang, WH; Teerlink, JR; Walsh, MN; Westlake Canary, CA | 1 |
Chiswell, K; Cleland, JG; Cotter, G; Davison, BA; Fiuzat, M; Givertz, MM; Mansoor, GA; Massie, BM; Metra, M; O'Connor, CM; Ponikowski, P; Stevens, S; Teerlink, JR; Voors, AA | 1 |
1 review(s) available for rolofylline and urea
Article | Year |
---|---|
Acute decompensated heart failure: update on new and emerging evidence and directions for future research.
Topics: Adrenomedullin; Atrial Natriuretic Factor; Biomarkers; Blood Pressure Monitoring, Ambulatory; Cardiotonic Agents; Clinical Trials as Topic; Diet, Sodium-Restricted; Diuretics; Dopamine; Dose-Response Relationship, Drug; Dyspnea; Glycopeptides; Heart Failure; Hemofiltration; Hospitalization; Humans; Natriuretic Agents; Natriuretic Peptide, Brain; Nitroglycerin; Peptide Fragments; Prognosis; Protein Precursors; Quality of Health Care; Relaxin; Risk Assessment; Saline Solution, Hypertonic; Urea; Vasodilator Agents; Xanthines | 2013 |
1 trial(s) available for rolofylline and urea
Article | Year |
---|---|
Predictors of postdischarge outcomes from information acquired shortly after admission for acute heart failure: a report from the Placebo-Controlled Randomized Study of the Selective A1 Adenosine Receptor Antagonist Rolofylline for Patients Hospitalized W
Topics: Aged; Blood Pressure; Creatinine; Diagnostic Tests, Routine; Female; Heart Failure; Humans; Kidney; Male; Middle Aged; Patient Discharge; Patient Readmission; Predictive Value of Tests; Purinergic P1 Receptor Antagonists; Serum Albumin; Sodium; Survival Rate; Treatment Outcome; Urea; Xanthines | 2014 |